Protenix — FoldBench published inference
5 seeds × 5 samples, 10 recycles; highest model ranking score. Paper-specific input/code adjustments; H800 80GB inference.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Evaluations and results
9 evaluations · 35 results. Different protocols are not a single leaderboard.
Sorted by lDDT (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
All 35 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 8.91 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.85 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 30.4 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 34.1% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench dna-monomer published full-set assessment Dataset: FoldBench dna-monomer published targets | 0.52 GDT ts fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench dna monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, GDT-TS row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench dna-monomer published full-set assessment Dataset: FoldBench dna-monomer published targets | 0.44 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench dna monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench dna-monomer published full-set assessment Dataset: FoldBench dna-monomer published targets | 7.4 RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench dna monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, RMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench dna-monomer published full-set assessment Dataset: FoldBench dna-monomer published targets | 0.28 TM score unitless · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench dna monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, TM-score row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-dna published full-set assessment Dataset: FoldBench protein-dna published targets | 5.08 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein dna protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, iRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-dna published full-set assessment Dataset: FoldBench protein-dna published targets | 0.83 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein dna protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-dna published full-set assessment Dataset: FoldBench protein-dna published targets | 11.6 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein dna protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, lRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-dna published full-set assessment Dataset: FoldBench protein-dna published targets | 68.4% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein dna protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, Success rate row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-ligand published full-set assessment Dataset: FoldBench protein-ligand published targets | 0.89 lDDT-LP fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein ligand protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, LDDT-LP row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-ligand published full-set assessment Dataset: FoldBench protein-ligand published targets | 0.7 lDDT-PLI fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein ligand protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, LDDT-PLI row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-ligand published full-set assessment Dataset: FoldBench protein-ligand published targets | 50.7% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein ligand protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, Success rate row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-monomer published full-set assessment Dataset: FoldBench protein-monomer published targets | 0.9 GDT ts fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, GDT-TS row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-monomer published full-set assessment Dataset: FoldBench protein-monomer published targets | 0.86 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-monomer published full-set assessment Dataset: FoldBench protein-monomer published targets | 2.04 RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, RMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-monomer published full-set assessment Dataset: FoldBench protein-monomer published targets | 0.93 TM score unitless · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein monomer protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, TM-score row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 2.93 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.83 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 8.44 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 77.1% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-protein published full-set assessment Dataset: FoldBench protein-protein published targets | 7.22 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein protein protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-protein block, iRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-protein published full-set assessment Dataset: FoldBench protein-protein published targets | 0.81 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein protein protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-protein block, LDDT row, Protenix column; Table 1 assessable count |
Source checking is not independent reproduction. Release 2026-11-02-a7f03c9e55a5.
Use this configuration
How it works, versions and access
Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
2 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Facets: method types1 values
| Benchmarking all-atom biomolecular structure prediction with FoldBench Matches other AlphaFold 3 and Chai-1 configurations Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | conflicting claim ["automated-source-review"] · 2026-10-12 Audit detailsCorrect the method type from none to foundation_model (use-case baseline review 2026-10-12, table 2). The review did not read FoldBench. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md. Conflicting source claim: Field: Claim: metadata-correction-tags-20261012-736ffa8de7e4bcb7cd58 Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Facets: method types1 values
| FoldBench supplementary target coverage and performance Matches other AlphaFold 3 and Chai-1 configurations Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | conflicting claim ["automated-source-review"] · 2026-10-12 Audit detailsCorrect the method type from none to foundation_model (use-case baseline review 2026-10-12, table 2). The review did not read FoldBench. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md. Conflicting source claim: Field: Claim: metadata-correction-tags-20261012-736ffa8de7e4bcb7cd58 Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-02-a7f03c9e55a5 · Record review: source checked
2 source records and release history
- Benchmarking all-atom biomolecular structure prediction with FoldBench · Original source · 10.1038/s41467-025-67127-3
- FoldBench supplementary target coverage and performance · Original source · Supplementary Information to 10.1038/s41467-025-67127-3
Technical metadata and extraction receipts
Stable ID: ucc-research-config-foldbench-protenix
- method types
- foundation_model
- review
- method: automated-source-review; reviewed at: 2026-09-30T21:43:56Z; note: Primary-source table transcription and scope review; no independent reproduction or human scientific review.; reviewer note: role: research coverage worker; reviewer: codex
- code commit
- ca0170c256cc1e39ac2b4f330401a6419f0e97f3
- samples
- 25
- recycles
- 10
- selection
- highest model ranking score
- missing metadata
- weights sha256: reason: unextracted
Related records
- configuration of: Protenix
- subject: Protenix — FoldBench published inference: facets.method_types
- system: foldbench antibody antigen protenix
- system: foldbench dna monomer protenix
- system: foldbench protein dna protenix
- system: foldbench protein ligand protenix
- system: foldbench protein monomer protenix
- system: foldbench protein peptide protenix
- system: foldbench protein protein protenix
- system: foldbench protein rna protenix
- system: foldbench rna monomer protenix